Wissenschaftliche Arbeiten

Doç. Dr. Tülay Eren

80 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. The relationship between localization and neutrophil lymphocyte ratio in colon carcinoma

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.398756 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  2. The effect of sarcopenia on acute chemotherapy toxicity in gastrointestinal cancer patients undergoing systemic therapy

    Annals of Oncology, 2018

    DOI 10.1093/annonc/mdy300.050 Frei zugänglicher VolltextQuelle: OpenAlex

  3. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?

    Cancer Biomarkers, 2018

    DOI 10.3233/cbm-171119 PMID 29562501 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  4. The Effect of Sarcopenia on Acute Chemotherapy Toxicity in Gastrointestinal Cancer Patients Undergoing Systemic Therapy

    AYBU AVESIS, 2018

    Quelle: OpenAlex

  5. Çoklu Primer Tümörler-Tek Merkez Deneyimi

    Dicle Medical Journal / Dicle Tip Dergisi, 2017

    DOI 10.5798/dicletip.362337 Frei zugänglicher VolltextQuelle: OpenAlex

  6. Hyperthermia and Radiotherapy Combination for Locoregional Recurrences of Breast Cancer: A Review

    Breast Cancer Management, 2017

    DOI 10.2217/bmt-2017-0011 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  7. Reduced Doses of Docetaxel and Cisplatinum Plus 5 Fluorouracil Combination Chemotherapy in Metastatic Esophagogastric Adenocarcinoma: The Impact on Outcomes

    International Journal of Hematology and Oncology, 2017

    DOI 10.4999/uhod.172022 Frei zugänglicher VolltextQuelle: OpenAlex

  8. Efficacy and tolerability of first-line chemotherapy in elderly patients (age ≥70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

    Annals of Oncology, 2016

    DOI 10.1093/annonc/mdw371.42 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  9. Abiraterone acetate as a possible cause of sudden cardiac death.

    PubMed, 2016

    PMID 27569102 1 Zitation (OpenAlex) Quelle: OpenAlex

  10. The real life outcomes of modified docetaxel and cisplatin plus fluorourasil regimen in patients with metastatic gastric cancer.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e15548 Quelle: OpenAlex

  11. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study

    Current Medical Research and Opinion, 2016

    DOI 10.1080/03007995.2016.1257984 PMID 27817239 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  12. Mide Kanserinde Tanı Anındaki Evre ile Patolojik Alt Tip ve Lokalizasyonun İlişkisi

    2015

    Quelle: OpenAlex

  13. The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15238 Frei zugänglicher VolltextQuelle: OpenAlex

  14. The Relationship Between Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Survival in Metastatic Gastric Cancer on Firstline Modified Docetaxel and Cisplatinum Plus 5 Fluorourasil Regimen: A Single Institute Experience

    Saudi Journal of Gastroenterology, 2015

    DOI 10.4103/1319-3767.166207 PMID 26458860 20 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  15. The role of the gastrectomy on survival in metastatic gastric cancer patients: A multicenter study of Anatolian Society of Medical Oncology (ASMO).

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15052 1 Zitation (OpenAlex) Quelle: OpenAlex

  16. Efficacy and safety of raltitrexed combinations with uracil-tegafur or Mitomycin C as salvage treatment in advanced colorectal cancer patients.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.3_suppl.662 Quelle: OpenAlex

  17. Impact of Adjuvant Treatment Modalities on Survival Outcomes in Curatively Resected Pancreatic and Periampullary Adenocarcinoma

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu334.79 PMID 26361410 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  18. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer

    Thoracic Cancer, 2014

    DOI 10.1111/1759-7714.12107 PMID 26763794 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Efficacy and Safety of Raltitrexed Combinations with Uracil-Tegafur or Mitomycin C as Salvage Treatment in Advanced Colorectal Cancer Patients: A Multicenter Study of Anatolian Society of Medical Oncology (ASMO)

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.4.1845 PMID 24641419 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e15045 Quelle: OpenAlex

  21. Evaluation of the Renal Function Using Cystatin C Level in the Patients Receiving Cisplatin-Based Chemotherapy

    Renal Failure, 2013

    DOI 10.3109/0886022x.2013.777929 PMID 23530579 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  22. Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.11.6287 PMID 24377519 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Arrhythmias during and after zoledronic acid infusion patients with bone metastasis

    Medical Oncology, 2013

    DOI 10.1007/s12032-013-0609-5 PMID 23690271 7 Zitationen (OpenAlex) Quelle: OpenAlex

  24. Metformin in diabetic pancreatic cancer patients: Benefit or not—Multicenter experience.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e15110 5 Zitationen (OpenAlex) Quelle: OpenAlex

  25. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14533 1 Zitation (OpenAlex) Quelle: OpenAlex

  26. Retrospective review of modified dose docetaxel, cisplatin, and 5-flourouracil (DCF) for the treatment of first-line metastatic gastric carcinomas.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e15175 Quelle: OpenAlex

  27. Efficacy and safety of oral etoposide maintenance therapy following cisplatin plus etoposide in advanced small cell lung cancers (Study of the Anatolian Society of Medical Oncology).

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e18546 Quelle: OpenAlex

  28. Arrhythmias during and after zoledronic acid infusion patients with bone metastasis.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e20614 Quelle: OpenAlex

  29. Retrospective analysis of octagenarian breast cancer patients: Multicenter retrospective study.

    Journal of Clinical Oncology, 2012

    DOI 10.1200/jco.2012.30.15_suppl.e11011 Quelle: OpenAlex

  30. Successful management of bevacizumab-associated surgical bleeding with an Ankaferd blood stopper.

    PubMed, 2011

    PMID 21790260 1 Zitation (OpenAlex) Quelle: OpenAlex